Investigational New Drug Clinical Trial by LU-177 Octreotate for Neuroendocrine cancers
Diagnostic Radiology
Radiation Oncology
64Cu-Dotatate diagnostic imaging
Lung NETs
Alpha Therapy PRRT
PET-CT Scan
225Ac-PSMA I&T therapy
177Lu-PSMA-617 treatment for prostate cancer
Cu-64 DOTATATE
Diagnostic imaging services including PET/CT scans, MRI, CT, Nuclear Medicine, Ultrasound, Mammography, X-Ray, Bone Densitometry
Positron Emission Tomography (PET)
monoclonal antibody imaging
PRRT for neuroendocrine cancers
PATHOLOGY
Osteoporosis
Molecular Diagnostic Imaging
Targeted Alpha-Emitter Radiopharmaceuticals
Nuclear Oncology
Pancreatic NETs
Lu-177 DOTATATE PRRT
Diagnostic imaging for neuroendocrine tumors
177Lu-DOTATATE clinical trial
Nuclear Medicine
Development of radiopharmaceuticals for cancer treatment
Diagnostic and Therapeutic Radiopharmaceuticals
Nuclear Medicine Study
lymphoscintigraphy in breast cancer
GI NETs
Cardiac SPECT Imaging
Peptide Receptor Radionuclide Therapy (PRRT)
Ga-68 DOTATATE
Therapeutic nuclear medicine treatments for neuroendocrine, prostate, brain, pancreatic, and ovarian cancers
Therapeutic Nuclear Medicine
Show Fewer services